Kaleido Biosciences

(OTC) KLDO

Current Price$0.00

Market Cap$4,300

Since IPO (2019)-100%

5 Year-100%

1 Year+0%

1 Month+0%

Kaleido Biosciences Financials at a Glance

Market Cap

$4,300

Revenue (TTM)

$1.10M

Net Income (TTM)

$91.95M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

3405.79 (High)

Dividend

$0.00

Beta (Volatility)

3405.79 (High)

Price

$0.00

Volume

865

Open

$0.00

Price

$0.00

Volume

865

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.35

Dividend

$0.00

Beta (Volatility)

3405.79 (High)

Price

$0.00

Volume

865

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.35

KLDO News

All the 2020 Pre-JPM News Healthcare Investors Need to Know

Brian Orelli, PhDJan 11, 2020

Will the Gut Microbiome Change Medicine? Wall Street Isn't Convinced.

Maxx ChatskoSep 17, 2019

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Kaleido Biosciences

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Daniel L. Menichella, MBA

Website

www.kaleido.com

Headquarters

Lexington, MA 02421, US

KLDO Financials

Key Financial Metrics (TTM)

Gross Margin

-1%

Operating Margin

-79%

Net Income Margin

-82%

Return on Equity

Return on Capital

-4%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.30K

Shares Outstanding

42.62M

Volume

865

Avg. Volume

1.16K

Financials (TTM)

Gross Profit

$1.25M

Operating Income

$87.67M

EBITDA

$85.09M

Operating Cash Flow

$77.09M

Capital Expenditure

$1.13M

Free Cash Flow

$78.22M

Cash & ST Invst.

$38.47M

Total Debt

$21.69M

Kaleido Biosciences Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q4 2021YOY CHG

Revenue

$492.00K

+102.5%

Gross Profit

$492.00K

+102.5%

Gross Margin

100.00%

N/A

Market Cap

$4.30K

N/A

Market Cap/Employee

$56.58

N/A

Employees

N/A

Net Income

$21.12M

-8.6%

EBITDA

$18.95M

-1.2%

Quarterly Fundamentals

Name

Q4 2021YOY CHG

Net Cash

$16.78M

-33.4%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$5.55M

-69.8%

Short Term Debt

$16.14M

+512.9%

Return on Assets

-1.80%

N/A

Return on Invested Capital

-4.29%

N/A

Free Cash Flow

$17.60M

-47.1%

Operating Cash Flow

$17.16M

-51.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

BXRXQBaudax Bio, Inc.

BXRXQBaudax Bio, Inc.$0.00+0.00%

IVBTInnovation1 Biotech Inc.

IVBTInnovation1 Biotech Inc.$0.00+0.00%

XENOXeno Transplants Corporation

XENOXeno Transplants Corporation$0.00+0.00%

TNGNQTengion, Inc.

TNGNQTengion, Inc.$0.00+0.00%

BTTXBetter Therapeutics, Inc.

BTTXBetter Therapeutics, Inc.$0.00+0.00%

SNNAQSienna Biopharmaceuticals, Inc.

SNNAQSienna Biopharmaceuticals, Inc.$0.00+0.00%

TLOGTetraLogic Pharmaceuticals Corporation

TLOGTetraLogic Pharmaceuticals Corporation$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

RXTRackspace Technology

RXTRackspace Technology$5.49+0.56%

NVDANvidia

NVDANvidia$215.20+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$15.62+0.08%

IRENIren

IRENIren$61.20+0.08%

NOKNokia

NOKNokia$12.82+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$76.28+0.07%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$42.57-0.07%

Questions About KLDO

What is the current price of Kaleido Biosciences?

Kaleido Biosciences is trading at $0.00 per share.

What is the 52-week range for Kaleido Biosciences?

Over the past 52 weeks, Kaleido Biosciences has traded between $0.00 and $0.35.

How much debt does Kaleido Biosciences have?

As of the most recent reporting period, Kaleido Biosciences reported total debt of $21.69M.

How much cash does Kaleido Biosciences have on hand?

Kaleido Biosciences reported $38.47M in cash and cash equivalents in its most recent financial results.

What is Kaleido Biosciences’s dividend yield?

Kaleido Biosciences does not currently have a dividend yield.

Kaleido Biosciences

Kaleido Biosciences Financials at a Glance

KLDO News

All the 2020 Pre-JPM News Healthcare Investors Need to Know

Will the Gut Microbiome Change Medicine? Wall Street Isn't Convinced.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Kaleido Biosciences

KLDO Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Kaleido Biosciences Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About KLDO

What is the current price of Kaleido Biosciences?

What is the 52-week range for Kaleido Biosciences?

How much debt does Kaleido Biosciences have?

How much cash does Kaleido Biosciences have on hand?

What is Kaleido Biosciences’s dividend yield?

Premium Investing Services